In today’s podcast, Nicole and Eloise sit down with host Jonah Comstock to talk about some of what they saw and heard at the show, including how digital health and digital therapeutics are shifting the paradigm of care sites, some lessons and discussions from the DtX Global Policy Summit, the World Economic Forum’s push for health equity and corporate accountability, and more. 

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Sarah Bateup, therapy lead at Clerkenwell Health, a British start-up working to revolutionise the clinical research landscape by providing a holistic one-stop hub for drug development, trial design, and treatment delivery for complex mental health and neurological conditions – including psychedelic medicines and braincare technologies, importantly in combination with a therapist.

On today’s podcast, host Jonah Comstock chats with Priya Baraniak, chief business officer and head of process development and manufacturing at OrganaBio and Lindsay Davis, chief scientific officer for NextCell Pharma, about how this tissue is currently collected and used and how this status quo may need to change.

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Neil Weir, CEO of Sitryx Therapeutics, a smaller biotech that specialises in immunometabolism – a rapidly emerging and exciting area of investigation into the role of intracellular metabolic pathways in immune cells.

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Venu Mallarapu, vice president of global strategy and operations at eClinical Solutions, about the ins and outs of successful AI implementation within pharma and healthcare.

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Nataliya Andreychuk, CEO of Viseven, about her personal battle with breast cancer.

In this week’s episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Raquel Izumi, chief operating officer and co-founder of Vincerx Pharma, who is on a mission to improve antibody drug conjugate (or ADC) drug development, aiming to conquer cancer with safe, well-tolerated, and paradigm-shifting therapeutics.

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with KimberLee Heidmann, executive vice president of patient experience and customer success at Scout Clinical, part of Meeting Protocol Worldwide, a Dallas-based family of brands providing full-service meeting planning for the pharmaceutical and biotechnology industry, as well as clinical trial patient concierge travel and reimbursement services.

This week the podcast welcomes Dr Rekha Kumar, medical affairs lead at digital medical weight loss clinic Found. Kumar discusses how her practice has had to carefully integrate these new drugs and navigate the complexities around prescribing them.

In this latest episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Sarah Watters, senior consultant at Wellth, a company devoted to improving the health of people with chronic conditions by embracing, not denying, humanity.